CHRO Chromocell Therapeutics
- 1.550
- +0.130+9.15%
Chromocell Therapeutics News
Chromocell Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Francis Knuettel II
Chromocell Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Simmons Chia-Lin
Chromocell Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lang Eric
Chromocell Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Friedberg Ezra M
Chromocell Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Malamut Richard
Chromocell Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Francis Knuettel II
Chromocell Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Davis Todd C
Chromocell Therapeutics | 424B3: Prospectus
Chromocell Therapeutics | 10-Q: Quarterly report
Chromocell Therapeutics | 424B3: Prospectus
Chromocell Therapeutics | 424B3: Prospectus
Chromocell Therapeutics | 424B3: Prospectus
Chromocell Therapeutics | POS EX: Post-effective amendment filed solely to add exhibits to a registration statement
Chromocell Therapeutics | 10-K: Annual report
Chromocell Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Chromocell Therapeutics | 8-K: Current report
Chromocell Therapeutics | NT 10-K: Others
Chromocell Therapeutics | 8-K: Current report
Chromocell Therapeutics | 8-K: Current report
Chromocell Therapeutics | 8-K: Current report
Analysis
Price Target
No Data
